ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis L Janssen, L Dupont, M Bekhouche, A Noel, C Leduc, M Voz, B Peers, ... Angiogenesis 19, 53-65, 2016 | 103 | 2016 |
Effects of platelet‐rich plasma (PRP) on the healing of A chilles tendons of rats JF Kaux, PV Drion, A Colige, F Pascon, V Libertiaux, A Hoffmann, ... Wound Repair and Regeneration 20 (5), 748-756, 2012 | 103 | 2012 |
Determination of the substrate repertoire of ADAMTS2, 3 and 14 significantly broadens their functions and identifies extracellular matrix organization and TGF-beta signaling as … M Bekhouche, C Leduc, L Dupont, L Janssen, F Delolme, VL Goff, ... FASEB Journal 5, 2016 | 92 | 2016 |
New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation R Delcombel, L Janssen, R Vassy, M Gammons, O Haddad, B Richard, ... Angiogenesis 16, 353-371, 2013 | 72 | 2013 |
Vascular Endothelial Growth Factor-111 (VEGF-111) and tendon healing: preliminary results in a rat model of tendon injury JF Kaux, L Janssen, P Drion, B Nusgens, V Libertiaux, F Pascon, ... Muscles, Ligaments and Tendons Journal 4 (1), 24, 2014 | 70 | 2014 |
Spontaneous atopic dermatitis due to immune dysregulation in mice lacking Adamts2 and 14 L Dupont, G Ehx, M Chantry, C Monseur, C Leduc, L Janssen, D Cataldo, ... Matrix Biology 70, 140-157, 2018 | 17 | 2018 |
ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis. L Dupont, L Janssen, M Bekhouche, A Noël, C Leduc, M Voz, B Peers, ... 2nd Matrix Biology Europe Conference, 2016 | | 2016 |
Study of a new splice variant of Neuropilin-1: Antagonistic functions in the regulation of tumor progression C Hendricks, L Janssen, R Delcombel, J Dubail, C Deroanne, A Colige Cancer Research 75 (15_Supplement), 5135-5135, 2015 | | 2015 |
Functional interactions between ADAMTS and VEGF: a specific focus on ADAMTS3 L Janssen Université de Liège, 2014 | | 2014 |
ADAMTS-3 deficiency is embryonic lethal in mouse and zebrafish. L Janssen, J Dubail, L Dupont, M Voz, B Peers, E Peyre, L Nguyen, ... 9TH Pan Pacific Connective Tissue Societies Symposium., 2013 | | 2013 |
Effects of platelet-rich plasma on the healing of tendons: animal model JF Kaux, P Drion, A Colige, F Pascon, V Libertiaux, A HOFFMANN, ... Biomedica 2012-The European Life Sciences Summit, 2012 | | 2012 |
Evaluation of the use of VEGF111 for the treatment of tendon lesions. L Janssen, JF Kaux, P Drion, R Delcombel, C Lambert, V Denoël, ... GIGA-Cancer Days, 2011 | | 2011 |
Evaluation of the potential interest of a VEGF chimeric variant (VEGF111b) in inhibition of angiogenesis. R Delcombel, L Janssen, R Vassy, O Haddad, D Letourneur, ... 3ème Congrès de la Société Française d'Angiogenèse, 2011 | | 2011 |
VEGF111, a diffusible and resistant-to-degradation variant of VEGF-A, induces the formation of a dense and characteristic network of small functional capillaries in vivo R Delcombel, L Janssen, P Mineur, NE Sounni, R Vassy, B Richard, ... | | 2011 |
Tendon lesion and VEGF-111 injection JF Kaux, P Drion, V Libertiaux, F Pascon, A Colige, C Le Goff, C Lambert, ... 6th Meeting of the EFOST, 2010 | | 2010 |